Clinical Trials
3 trialsNCT05768932 2026-03-27
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
SillaJen, Inc.
Phase 1 Recruiting
NCT06538896 2024-11-26
Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT04501523 2023-02-21
Apollo
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting